Tower Research Capital LLC (Trc) Landec Corp \Ca\ Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 34 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34Holding current value
$0% of portfolio
0.0%Shares
25 transactions
Others Institutions Holding LNDC
# of Institutions
77Shares Held
20.2MCall Options Held
114KPut Options Held
82.1K-
Wynnefield Capital Inc New York, NY4.92MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA2.95MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.14MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
325 Capital LLC New York, NY1.34MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...